Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) released a grim second quarter print last Thursday, revealing that the management team had lowered guidance across …
Days are becoming tough for Gilead Sciences, Inc. (NASDAQ:GILD) as it recently released its 1Q17 earnings report.
